MGMT and glioblastoma: In patients with newly-diagnosed glioblastoma, temozolomide (TMZ) is the standard of treatment; however, a challenge exists in overcoming TMZ drug resistance mainly due to O6-methylguanine DNA methyltransferase (MGMT).